Nektar Therapeutics (NKTR)
USD 0.75
(-3.6%)
USD 0.75
(-3.6%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -276.05 Million USD | 25.03% |
| 2022 | -368.19 Million USD | 29.71% |
| 2021 | -523.83 Million USD | -17.86% |
| 2020 | -444.44 Million USD | -0.86% |
| 2019 | -440.66 Million USD | -164.68% |
| 2018 | 681.31 Million USD | 804.62% |
| 2017 | -96.69 Million USD | 37.02% |
| 2016 | -153.52 Million USD | -89.12% |
| 2015 | -81.17 Million USD | -50.56% |
| 2014 | -53.91 Million USD | 66.72% |
| 2013 | -162.01 Million USD | 5.73% |
| 2012 | -171.85 Million USD | -28.27% |
| 2011 | -133.97 Million USD | -253.15% |
| 2010 | -37.93 Million USD | 62.99% |
| 2009 | -102.51 Million USD | -198.58% |
| 2008 | -34.33 Million USD | -4.81% |
| 2007 | -32.76 Million USD | 78.83% |
| 2006 | -154.76 Million USD | 16.4% |
| 2005 | -185.11 Million USD | -81.68% |
| 2004 | -101.88 Million USD | -118.26% |
| 2003 | -46.68 Million USD | 56.56% |
| 2002 | -107.46 Million USD | 57.01% |
| 2001 | -250 Million USD | -156.67% |
| 2000 | -97.4 Million USD | -153.34% |
| 1999 | -38.44 Million USD | -109.46% |
| 1998 | -18.35 Million USD | -83.87% |
| 1997 | -9.98 Million USD | 0.17% |
| 1996 | -10 Million USD | -29.87% |
| 1995 | -7.7 Million USD | -45.28% |
| 1994 | -5.3 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -52.36 Million USD | -42.28% |
| 2024 Q1 | -36.8 Million USD | 12.54% |
| 2023 Q4 | -42.07 Million USD | 8.2% |
| 2023 Q3 | -45.83 Million USD | 10.34% |
| 2023 Q2 | -51.12 Million USD | 62.69% |
| 2023 FY | -276.05 Million USD | 25.03% |
| 2023 Q1 | -137.01 Million USD | -129.56% |
| 2022 FY | -368.19 Million USD | 29.71% |
| 2022 Q4 | -59.68 Million USD | -1.08% |
| 2022 Q3 | -59.04 Million USD | 62.88% |
| 2022 Q2 | -159.06 Million USD | -75.97% |
| 2022 Q1 | -90.39 Million USD | 37.94% |
| 2021 FY | -523.83 Million USD | -17.86% |
| 2021 Q2 | -125.51 Million USD | -2.08% |
| 2021 Q3 | -129.7 Million USD | -3.34% |
| 2021 Q4 | -145.64 Million USD | -12.29% |
| 2021 Q1 | -122.96 Million USD | -4.92% |
| 2020 Q1 | -138.65 Million USD | -23.61% |
| 2020 Q3 | -108.58 Million USD | -35.73% |
| 2020 Q2 | -80 Million USD | 42.3% |
| 2020 Q4 | -117.2 Million USD | -7.94% |
| 2020 FY | -444.44 Million USD | -0.86% |
| 2019 Q1 | -118.51 Million USD | -20.67% |
| 2019 Q2 | -109.9 Million USD | 7.26% |
| 2019 Q3 | -98.8 Million USD | 10.1% |
| 2019 Q4 | -112.16 Million USD | -13.52% |
| 2019 FY | -440.66 Million USD | -164.68% |
| 2018 Q1 | -95.79 Million USD | -183.19% |
| 2018 Q3 | -96.14 Million USD | -109.9% |
| 2018 Q2 | 971.46 Million USD | 1114.13% |
| 2018 Q4 | -98.21 Million USD | -2.15% |
| 2018 FY | 681.31 Million USD | 804.62% |
| 2017 Q1 | -63.86 Million USD | -51.34% |
| 2017 Q3 | 60.87 Million USD | 201.67% |
| 2017 Q4 | -33.82 Million USD | -155.57% |
| 2017 FY | -96.69 Million USD | 37.02% |
| 2017 Q2 | -59.87 Million USD | 6.26% |
| 2016 Q1 | -19.49 Million USD | 63.98% |
| 2016 Q3 | -43.22 Million USD | 11.07% |
| 2016 Q4 | -42.19 Million USD | 2.37% |
| 2016 FY | -153.52 Million USD | -89.12% |
| 2016 Q2 | -48.6 Million USD | -149.27% |
| 2015 Q4 | -54.13 Million USD | -559.97% |
| 2015 Q2 | -52.65 Million USD | -255.7% |
| 2015 FY | -81.17 Million USD | -50.56% |
| 2015 Q3 | -8.2 Million USD | 84.42% |
| 2015 Q1 | 33.82 Million USD | 174.03% |
| 2014 Q1 | -46.2 Million USD | 3.06% |
| 2014 FY | -53.91 Million USD | 66.72% |
| 2014 Q2 | -32.63 Million USD | 29.36% |
| 2014 Q3 | 70.6 Million USD | 316.33% |
| 2014 Q4 | -45.68 Million USD | -164.7% |
| 2013 Q4 | -47.65 Million USD | -188.09% |
| 2013 Q2 | -42.74 Million USD | 22.37% |
| 2013 FY | -162.01 Million USD | 5.73% |
| 2013 Q1 | -55.06 Million USD | -4.04% |
| 2013 Q3 | -16.54 Million USD | 61.3% |
| 2012 Q1 | -41.09 Million USD | -9.61% |
| 2012 FY | -171.85 Million USD | -28.27% |
| 2012 Q4 | -52.92 Million USD | -21.54% |
| 2012 Q3 | -43.54 Million USD | -27.01% |
| 2012 Q2 | -34.28 Million USD | 16.58% |
| 2011 Q3 | -24.06 Million USD | 33.84% |
| 2011 Q2 | -36.38 Million USD | -0.96% |
| 2011 Q4 | -37.49 Million USD | -55.79% |
| 2011 FY | -133.97 Million USD | -253.15% |
| 2011 Q1 | -36.03 Million USD | -59.58% |
| 2010 Q2 | -517 Thousand USD | 91.57% |
| 2010 FY | -37.93 Million USD | 62.99% |
| 2010 Q4 | -22.58 Million USD | -159.21% |
| 2010 Q3 | -8.71 Million USD | -1584.91% |
| 2010 Q1 | -6.13 Million USD | 20.14% |
| 2009 Q3 | -30.96 Million USD | 3.44% |
| 2009 Q1 | -31.8 Million USD | -141.43% |
| 2009 FY | -102.51 Million USD | -198.58% |
| 2009 Q4 | -7.67 Million USD | 75.21% |
| 2009 Q2 | -32.06 Million USD | -0.82% |
| 2008 Q1 | -40.7 Million USD | -204.26% |
| 2008 Q3 | -37.03 Million USD | -10.98% |
| 2008 Q4 | 76.78 Million USD | 307.31% |
| 2008 FY | -34.33 Million USD | -4.81% |
| 2008 Q2 | -33.37 Million USD | 18.01% |
| 2007 Q1 | -25.67 Million USD | 33.93% |
| 2007 Q3 | -18.62 Million USD | 32.32% |
| 2007 FY | -32.76 Million USD | 78.83% |
| 2007 Q2 | -27.51 Million USD | -7.16% |
| 2007 Q4 | 39.04 Million USD | 309.68% |
| 2006 FY | -154.76 Million USD | 16.4% |
| 2006 Q4 | -38.85 Million USD | -98.2% |
| 2006 Q3 | -19.6 Million USD | 68.8% |
| 2006 Q2 | -62.83 Million USD | -87.72% |
| 2006 Q1 | -33.47 Million USD | 69.08% |
| 2005 Q1 | -26.16 Million USD | -35.78% |
| 2005 Q2 | -26.91 Million USD | -2.85% |
| 2005 Q3 | -23.79 Million USD | 11.58% |
| 2005 Q4 | -108.23 Million USD | -354.88% |
| 2005 FY | -185.11 Million USD | -81.68% |
| 2004 Q2 | -22.16 Million USD | 44.59% |
| 2004 Q3 | -20.45 Million USD | 7.72% |
| 2004 Q4 | -19.27 Million USD | 5.78% |
| 2004 FY | -101.88 Million USD | -118.26% |
| 2004 Q1 | -40 Million USD | -1238.95% |
| 2003 Q3 | -17.2 Million USD | -31.96% |
| 2003 FY | -46.68 Million USD | 56.56% |
| 2003 Q4 | 3.51 Million USD | 120.41% |
| 2003 Q2 | -13.03 Million USD | 34.64% |
| 2003 Q1 | -19.94 Million USD | 35.8% |
| 2002 Q3 | -26.52 Million USD | -6.87% |
| 2002 Q2 | -24.81 Million USD | 0.95% |
| 2002 FY | -107.46 Million USD | 57.01% |
| 2002 Q1 | -25.05 Million USD | 30.88% |
| 2002 Q4 | -31.07 Million USD | -17.17% |
| 2001 Q4 | -36.25 Million USD | -34.66% |
| 2001 Q3 | -26.92 Million USD | 74.55% |
| 2001 FY | -250 Million USD | -156.67% |
| 2001 Q2 | -105.79 Million USD | -30.54% |
| 2001 Q1 | -81.04 Million USD | -104.6% |
| 2000 Q4 | -39.6 Million USD | -199.73% |
| 2000 Q2 | -15.74 Million USD | 45.38% |
| 2000 Q1 | -28.83 Million USD | -42.92% |
| 2000 FY | -97.4 Million USD | -153.34% |
| 2000 Q3 | -13.21 Million USD | 16.08% |
| 1999 FY | -38.44 Million USD | -109.46% |
| 1999 Q2 | -6 Million USD | -14.99% |
| 1999 Q1 | -5.22 Million USD | 17.29% |
| 1999 Q4 | -20.17 Million USD | -186.36% |
| 1999 Q3 | -7.04 Million USD | -17.3% |
| 1998 FY | -18.35 Million USD | -83.87% |
| 1998 Q4 | -6.31 Million USD | -25.25% |
| 1998 Q3 | -5.04 Million USD | -76.91% |
| 1998 Q2 | -2.85 Million USD | 31.31% |
| 1998 Q1 | -4.14 Million USD | -38.76% |
| 1997 Q1 | -2.04 Million USD | 39.88% |
| 1997 Q4 | -2.99 Million USD | -12.79% |
| 1997 Q3 | -2.65 Million USD | -15.36% |
| 1997 Q2 | -2.29 Million USD | -12.43% |
| 1997 FY | -9.98 Million USD | 0.17% |
| 1996 Q2 | -2.5 Million USD | -31.58% |
| 1996 Q3 | -2.3 Million USD | 8.0% |
| 1996 Q4 | -3.4 Million USD | -47.83% |
| 1996 FY | -10 Million USD | -29.87% |
| 1996 Q1 | -1.9 Million USD | 17.39% |
| 1995 Q1 | -2.2 Million USD | 4.35% |
| 1995 Q3 | -1.7 Million USD | -6.25% |
| 1995 Q4 | -2.3 Million USD | -35.29% |
| 1995 FY | -7.7 Million USD | -45.28% |
| 1995 Q2 | -1.6 Million USD | 27.27% |
| 1994 Q4 | -2.3 Million USD | -155.56% |
| 1994 FY | -5.3 Million USD | 0.0% |
| 1994 Q2 | -900 Thousand USD | 18.18% |
| 1994 Q1 | -1.1 Million USD | 0.0% |
| 1994 Q3 | -900 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -7.069% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -144.382% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -29393.162% |
| Autolus Therapeutics plc | -208.38 Million USD | -32.475% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -3004.612% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -849.69% |
| Shattuck Labs, Inc. | -87.29 Million USD | -216.223% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -121.463% |
| CervoMed Inc. | -2.17 Million USD | -12610.504% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -12.403% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -518.914% |
| Aptose Biosciences Inc. | -51.2 Million USD | -439.098% |
| Precision BioSciences, Inc. | -61.31 Million USD | -350.197% |
| Dyadic International, Inc. | -6.79 Million USD | -3962.359% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -209.417% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -2519.624% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -48415.993% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -870.252% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -289.937% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -239.077% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -22.555% |
| GRI Bio, Inc. | -13.03 Million USD | -2017.481% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -6576.764% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -122.475% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -2631.335% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -439.603% |
| IGM Biosciences, Inc. | -246.41 Million USD | -12.028% |
| INmune Bio, Inc. | -30 Million USD | -819.941% |
| Opthea Limited | -220.24 Million USD | -25.342% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -362.522% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -183.344% |
| Verastem, Inc. | -87.36 Million USD | -215.973% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -409.441% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -71.106% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -136.637% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 629.309% |
| NextCure, Inc. | -62.72 Million USD | -340.119% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -1350.721% |
| Organovo Holdings, Inc. | -14.67 Million USD | -1781.644% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -5326.665% |
| Arvinas, Inc. | -367.3 Million USD | 24.842% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -427.439% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -924.783% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -712.646% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -82.716% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -828.7% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -67.74% |
| Senti Biosciences, Inc. | -92.91 Million USD | -197.093% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -2549.874% |
| Apollomics, Inc. | -172.6 Million USD | -59.939% |
| PureTech Health plc | -65.69 Million USD | -320.196% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -599.248% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -276.37% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -87.842% |
| Synaptogenix, Inc. | -6.03 Million USD | -4471.596% |
| ChromaDex Corporation | -4.93 Million USD | -5490.441% |
| Beam Therapeutics Inc. | -132.52 Million USD | -108.302% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -3185.522% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -431.644% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -91.775% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 47.779% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -3441.59% |
| Gritstone bio, Inc. | -138.49 Million USD | -99.333% |
| Mesoblast Limited | -87.95 Million USD | -213.857% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -1717.412% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -343.428% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -71.54% |
| MediWound Ltd. | -6.71 Million USD | -4010.423% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -54.176% |
| Fortress Biotech, Inc. | -60.63 Million USD | -355.26% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -258.091% |
| Achilles Therapeutics plc | -69.66 Million USD | -296.262% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -142.742% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -432.444% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -817.312% |
| Zai Lab Limited | -334.62 Million USD | 17.502% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -4748.191% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -17.655% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 11102.631% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -103.142% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -3496.563% |
| FibroGen, Inc. | -284.23 Million USD | 2.877% |
| Celcuity Inc. | -63.77 Million USD | -332.831% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -952.364% |
| ContextLogic Inc. | -317 Million USD | 12.916% |
| GH Research PLC | -35.58 Million USD | -675.721% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -238.387% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -1123.924% |
| ImmuCell Corporation | -5.77 Million USD | -4680.523% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 660.281% |
| Amarin Corporation plc | -59.11 Million USD | -367.005% |
| TG Therapeutics, Inc. | 12.67 Million USD | 2278.472% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -1485.526% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -328.226% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -180.471% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -1188.356% |
| Aptorum Group Limited | -2.82 Million USD | -9673.115% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 54.494% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -21.858% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -1039.738% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -34.481% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -1388.486% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -136.353% |
| Ardelyx, Inc. | -66.06 Million USD | -317.842% |
| Ainos, Inc. | -13.77 Million USD | -1904.684% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -340.421% |
| Prothena Corporation plc | -147.02 Million USD | -87.757% |
| HilleVax, Inc. | -123.56 Million USD | -123.408% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -142.429% |
| Celularity Inc. | -196.29 Million USD | -40.633% |
| Rallybio Corporation | -74.56 Million USD | -270.227% |
| Cue Biopharma, Inc. | -50.73 Million USD | -444.135% |
| Omeros Corporation | -117.81 Million USD | -134.317% |
| Humacyte, Inc. | -110.77 Million USD | -149.202% |
| Immunocore Holdings plc | -55.28 Million USD | -399.314% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -1435.009% |
| Blueprint Medicines Corporation | -506.98 Million USD | 45.549% |
| IO Biotech, Inc. | -86.08 Million USD | -220.686% |
| MEI Pharma, Inc. | 17.77 Million USD | 1652.796% |
| GT Biopharma, Inc. | -7.59 Million USD | -3533.75% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -307.914% |
| Summit Therapeutics Inc. | -614.92 Million USD | 55.108% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -685.589% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -95.224% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -66.51% |
| Pulmatrix, Inc. | -14.12 Million USD | -1854.932% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -684.361% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -172.872% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -234.055% |
| Acelyrin, Inc. | -381.64 Million USD | 27.666% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 42.631% |
| Cytokinetics, Incorporated | -526.24 Million USD | 47.542% |
| Vor Biopharma Inc. | -117.86 Million USD | -134.218% |
| Evogene Ltd. | -23.87 Million USD | -1056.062% |
| Replimune Group, Inc. | -215.79 Million USD | -27.926% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -130.502% |
| PDS Biotechnology Corporation | -42.94 Million USD | -542.855% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -3418.703% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 57.081% |
| AEON Biopharma, Inc. | -52.55 Million USD | -425.261% |
| BioLineRx Ltd. | -60.61 Million USD | -355.433% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -572.225% |
| Atai Life Sciences N.V. | -40.22 Million USD | -586.297% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -265.535% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -840.181% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | 5.522% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -890.3% |
| MediciNova, Inc. | -8.57 Million USD | -3120.62% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -123.931% |
| MiMedx Group, Inc. | 67.43 Million USD | 509.342% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -3195.469% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -15.39% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 55.944% |
| Mereo BioPharma Group plc | -29.46 Million USD | -836.863% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -31.857% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -815.609% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -17.004% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -5661.41% |
| Allakos Inc. | -185.7 Million USD | -48.656% |
| scPharmaceuticals Inc. | -54.81 Million USD | -403.66% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -183.614% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 360.087% |
| NLS Pharmaceutics AG | -12.17 Million USD | -2167.954% |
| Precigen, Inc. | -95.9 Million USD | -187.846% |
| XOMA Corporation | -40.83 Million USD | -576.094% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -170.989% |
| Incyte Corporation | 597.59 Million USD | 146.194% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -2675.061% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -132.933% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -214.848% |
| Seer, Inc. | -86.27 Million USD | -219.965% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1034.199% |
| CRISPR Therapeutics AG | -153.61 Million USD | -79.712% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -81.904% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -686.059% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -3311.493% |
| Akari Therapeutics, Plc | -10 Million USD | -2658.353% |
| Novavax, Inc. | -545.06 Million USD | 49.353% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -4041.938% |
| UroGen Pharma Ltd. | -102.24 Million USD | -169.997% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -158.496% |
| Entera Bio Ltd. | -8.88 Million USD | -3005.591% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -1224.645% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -163.666% |
| Chimerix, Inc. | -82.09 Million USD | -236.264% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -256.717% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -36.938% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -368.029% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 166.546% |
| AnaptysBio, Inc. | -163.61 Million USD | -68.719% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -1832.251% |
| Portage Biotech Inc. | -75.33 Million USD | -266.418% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -185.61% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -300.313% |
| OKYO Pharma Limited | -16.82 Thousand USD | -1640604.028% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -1957.477% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -3203.257% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -2382.179% |
| AbCellera Biologics Inc. | -146.39 Million USD | -88.565% |
| Genprex, Inc. | -30.86 Million USD | -794.53% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -17.01% |
| NLS Pharmaceutics AG | -12.17 Million USD | -2167.954% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -5112.523% |
| Daré Bioscience, Inc. | -30.16 Million USD | -815.263% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -4857.012% |
| Bicycle Therapeutics plc | -180.66 Million USD | -52.801% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 36.738% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -249.637% |
| Erasca, Inc. | -125.04 Million USD | -120.771% |
| bluebird bio, Inc. | -211.91 Million USD | -30.269% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -1024.785% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 264.667% |
| DBV Technologies S.A. | -72.72 Million USD | -279.584% |
| Fortress Biotech, Inc. | -60.63 Million USD | -355.26% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -30.08% |
| CorMedix Inc. | -46.33 Million USD | -495.729% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -147.808% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -709.525% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -462.003% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -476.089% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -95.191% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -25.646% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -43.473% |
| Onconetix, Inc. | -37.4 Million USD | -637.926% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -2664.43% |
| Prime Medicine, Inc. | -198.13 Million USD | -39.329% |
| Adagene Inc. | -18.94 Million USD | -1357.039% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -14.375% |
| GlycoMimetics, Inc. | -36.89 Million USD | -648.131% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -131.923% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -37.981% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 308.612% |
| SciSparc Ltd. | -5.12 Million USD | -5289.613% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -229460.763% |
| Minerva Neurosciences, Inc. | -30 Million USD | -820.023% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -278.724% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 1310.453% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -409934.905% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -5.309% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -1865.386% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 37.294% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -2695.787% |
| 2seventy bio, Inc. | -217.57 Million USD | -26.881% |
| ADMA Biologics, Inc. | -28.23 Million USD | -877.57% |
| Clene Inc. | -49.5 Million USD | -457.644% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -1138.611% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -458.433% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | 15.854% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -748.283% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 1315.035% |
| Absci Corporation | -110.56 Million USD | -149.675% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 106.982% |
| Surrozen, Inc. | -43.04 Million USD | -541.364% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -170.458% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -373.566% |
| Cingulate Inc. | -23.53 Million USD | -1072.962% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -3893.866% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -3480.18% |
| Jaguar Health, Inc. | -41.3 Million USD | -568.416% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -206.015% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -350.439% |
| Kronos Bio, Inc. | -112.67 Million USD | -145.006% |
| Innoviva, Inc. | 179.72 Million USD | 253.602% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -298.942% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -4029.484% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -180.836% |
| Soligenix, Inc. | -6.14 Million USD | -4395.492% |
| AlloVir, Inc. | -190.41 Million USD | -44.974% |
| Century Therapeutics, Inc. | -136.67 Million USD | -101.983% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -174.145% |
| Kura Oncology, Inc. | -152.63 Million USD | -80.865% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 48918.859% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -283.955% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -1174.026% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -639.304% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -149.691% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -554.257% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1629.495% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -1647.745% |
| HCW Biologics Inc. | -24.99 Million USD | -1004.477% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -108.355% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | 0.025% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -16.043% |
| Lantern Pharma Inc. | -15.96 Million USD | -1629.508% |
| Histogen Inc. | -10.62 Million USD | -2499.153% |
| Surrozen, Inc. | -43.04 Million USD | -541.364% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -584.561% |
| Kodiak Sciences Inc. | -260.49 Million USD | -5.975% |
| MoonLake Immunotherapeutics | -36 Million USD | -666.668% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -464.231% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -135.613% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -775.146% |
| Moderna, Inc. | -4.71 Billion USD | 94.144% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 24.634% |
| Turnstone Biologics Corp. | -55.2 Million USD | -400.101% |
| Immix Biopharma, Inc. | -15.42 Million USD | -1689.545% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -1603.208% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -253.827% |
| Exelixis, Inc. | 207.76 Million USD | 232.869% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -103.954% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -379.989% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -51499.252% |
| Alkermes plc | 355.75 Million USD | 177.597% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -328.226% |
| Arcellx, Inc. | -70.69 Million USD | -290.516% |
| ESSA Pharma Inc. | -26.58 Million USD | -938.494% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -6801.486% |
| Avid Bioservices, Inc. | -140.75 Million USD | -96.128% |
| Insmed Incorporated | -749.56 Million USD | 63.171% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -566.142% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -106.295% |
| Moolec Science SA | -51.78 Million USD | -433.041% |
| RenovoRx, Inc. | -10.23 Million USD | -2597.967% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -427.116% |
| Geron Corporation | -184.12 Million USD | -49.927% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -557.683% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -312.055% |
| Royalty Pharma plc | 1.13 Billion USD | 124.326% |
| OmniAb, Inc. | -50.61 Million USD | -445.36% |
| Alector, Inc. | -130.39 Million USD | -111.714% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -103.048% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -60.806% |
| Humacyte, Inc. | -110.77 Million USD | -149.202% |
| Structure Therapeutics Inc. | -89.62 Million USD | -208.029% |
| Revance Therapeutics, Inc. | -323.98 Million USD | 14.794% |
| 89bio, Inc. | -142.18 Million USD | -94.147% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -2560.268% |
| Aura Biosciences, Inc. | -76.4 Million USD | -261.292% |
| Immunic, Inc. | -93.61 Million USD | -194.894% |
| Veracyte, Inc. | -74.4 Million USD | -271.023% |
| Genelux Corporation | -28.29 Million USD | -875.566% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -849.788% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -3842.593% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -1365.834% |
| Immunovant, Inc. | -259.33 Million USD | -6.447% |
| Vericel Corporation | -3.18 Million USD | -8575.55% |
| Fortrea Holdings Inc. | -3.4 Million USD | -8019.294% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -117.978% |
| XBiotech Inc. | -24.55 Million USD | -1024.144% |
| Agenus Inc. | -245.76 Million USD | -12.327% |
| Acasti Pharma Inc. | -12.85 Million USD | -2047.794% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -2105.996% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -1129.218% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1629.495% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -400.165% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -304.448% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -2113.761% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -1139.725% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -836.069% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -913.496% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -49.48% |
| United Therapeutics Corporation | 984.8 Million USD | 128.032% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -5121.832% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -5661.41% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -5326.665% |
| Silo Pharma, Inc. | -3.7 Million USD | -7359.596% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -2011.833% |
| Pharming Group N.V. | -10.54 Million USD | -2517.141% |
| XOMA Corporation | -40.83 Million USD | -576.094% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1034.199% |
| Bionomics Limited | -15.49 Billion USD | 98.218% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -846.792% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -274.11% |
| uniQure N.V. | -308.47 Million USD | 10.51% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -261.311% |
| Cassava Sciences, Inc. | -97.21 Million USD | -183.959% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -7230.798% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -1260.485% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -123.654% |
| Pluri Inc. | -20.88 Million USD | -1221.601% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -3265.838% |
| MeiraGTx Holdings plc | -84.02 Million USD | -228.532% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -1103.855% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -1476.909% |
| CalciMedica, Inc. | -34.35 Million USD | -703.493% |
| Sana Biotechnology, Inc. | -283.25 Million USD | 2.542% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -82.114% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -2200831.379% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -846.792% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -163.234% |
| Nutriband Inc. | -5.48 Million USD | -4932.638% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -582.969% |
| Compugen Ltd. | -18.75 Million USD | -1371.985% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 106.348% |
| ProKidney Corp. | -35.46 Million USD | -678.324% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -5420.571% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -6317.643% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -171.324% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -242.288% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -499.483% |
| Benitec Biopharma Inc. | -21.75 Million USD | -1169.165% |
| GeoVax Labs, Inc. | -25.96 Million USD | -963.113% |
| Biomea Fusion, Inc. | -117.25 Million USD | -135.432% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -80.238% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -173.765% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 2060.068% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -1140.144% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | 18.517% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -43.062% |
| Imunon, Inc. | -19.51 Million USD | -1314.585% |
| BioAtla, Inc. | -123.46 Million USD | -123.596% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | 15.648% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -647.127% |
| Zura Bio Limited | -60.36 Million USD | -357.349% |
| aTyr Pharma, Inc. | -50.38 Million USD | -447.85% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 26.115% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -16.12% |
| Galecto, Inc. | -38.34 Million USD | -619.852% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -409934.905% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 198.033% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -55.859% |
| PolyPid Ltd. | -23.86 Million USD | -1056.74% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -1654.742% |
| Forte Biosciences, Inc. | -31.47 Million USD | -777.036% |
| Xencor, Inc. | -126.08 Million USD | -118.941% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -1198.077% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -4041.938% |
| Instil Bio, Inc. | -156.08 Million USD | -76.86% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -3195.469% |
| OncoCyte Corporation | -27.78 Million USD | -893.686% |
| Elevation Oncology, Inc. | -45.7 Million USD | -504.008% |
| Purple Biotech Ltd. | -19.88 Million USD | -1288.612% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -3832.982% |
| MacroGenics, Inc. | -9.05 Million USD | -2947.648% |
| Verona Pharma plc | -54.36 Million USD | -407.745% |
| Tharimmune, Inc. | -9.31 Million USD | -2862.262% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -228.697% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -176.285% |
| Aditxt, Inc. | -32.38 Million USD | -752.529% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -15391.358% |
| Savara Inc. | -54.69 Million USD | -404.691% |
| Curis, Inc. | -47.41 Million USD | -482.237% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -1687.339% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -825.896% |
| BeiGene, Ltd. | -881.7 Million USD | 68.691% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -5420.571% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -587.442% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -1973.115% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -357.137% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -1000.219% |
| Adicet Bio, Inc. | -142.65 Million USD | -93.509% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3675.526% |
| Quantum-Si incorporated | -95.96 Million USD | -187.678% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -1793.678% |
| Generation Bio Co. | -126.61 Million USD | -118.033% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -234.849% |
| Invivyd, Inc. | -198.64 Million USD | -38.971% |
| Relay Therapeutics, Inc. | -341.97 Million USD | 19.275% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -3077.962% |
| Moolec Science SA | -51.78 Million USD | -433.041% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -749.795% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -407.251% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -179.432% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -71.671% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 55.117% |
| Evaxion Biotech A/S | -22.12 Million USD | -1147.711% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -241.924% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -299.306% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -592.564% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -363.936% |
| Clearmind Medicine Inc. | -11.95 Million USD | -2209.12% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -319.761% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 486.579% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -10884401.8% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -221.388% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -80.438% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -28.68% |
| ImmunityBio, Inc. | -583.19 Million USD | 52.665% |
| Korro Bio, Inc. | -81.17 Million USD | -240.088% |
| Kineta, Inc. | -14.09 Million USD | -1857.983% |
| BioVie Inc. | -32.12 Million USD | -759.438% |
| Codexis, Inc. | -76.24 Million USD | -262.088% |
| Celularity Inc. | -196.29 Million USD | -40.633% |
| Virax Biolabs Group Limited | -6.73 Million USD | -3999.718% |
| Cibus, Inc. | -267.62 Million USD | -3.15% |
| Annexon, Inc. | -134.23 Million USD | -105.648% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -350.866% |
| Eyenovia, Inc. | -27.26 Million USD | -912.637% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 1378.57% |
| NeurAxis, Inc. | -14.62 Million USD | -1787.345% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -819.053% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -549.635% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -1199.501% |
| Notable Labs, Ltd. | -11.26 Million USD | -2350.781% |
| IN8bio, Inc. | -30 Million USD | -819.972% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -1324.364% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -187.588% |
| Lumos Pharma, Inc. | -34.03 Million USD | -711.118% |
| Liquidia Corporation | -78.5 Million USD | -251.655% |
| Mustang Bio, Inc. | -51.6 Million USD | -434.972% |
| Quantum-Si incorporated | -95.96 Million USD | -187.678% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -278.943% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -176.285% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -407.783% |
| 180 Life Sciences Corp. | -19.93 Million USD | -1284.773% |
| Vaxcyte, Inc. | -402.26 Million USD | 31.375% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -51.352% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3675.526% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -232.782% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 9274.984% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -10884401.8% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -608.054% |
| PepGen Inc. | -78.62 Million USD | -251.1% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -827.327% |
| Solid Biosciences Inc. | -96.01 Million USD | -187.513% |
| Palisade Bio, Inc. | -12.3 Million USD | -2144.358% |
| Nutriband Inc. | -5.48 Million USD | -4932.638% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -51499.252% |
| Immuneering Corporation | -53.47 Million USD | -416.266% |
| Belite Bio, Inc | -31.63 Million USD | -772.711% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -467.935% |
| GeoVax Labs, Inc. | -25.96 Million USD | -963.113% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -555.341% |
| Altimmune, Inc. | -88.44 Million USD | -212.115% |
| Peak Bio, Inc. | -1259.26 USD | -21921981.222% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -952.364% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -1574.589% |
| Neurogene Inc. | -36.31 Million USD | -660.129% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -68.929% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -3147.336% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -181.268% |
| Sesen Bio, Inc. | -19.88 Million USD | -1288.332% |
| argenx SE | -295.05 Million USD | 6.439% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -232.782% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -533.81% |
| Immunome, Inc. | -106.8 Million USD | -158.465% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -1596362.586% |
| Design Therapeutics, Inc. | -66.86 Million USD | -312.874% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -628.726% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -285.639% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 37.83% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -147.437% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -104.308% |
| Athira Pharma, Inc. | -117.67 Million USD | -134.598% |
| XOMA Corporation | -40.83 Million USD | -576.094% |
| Merus N.V. | -154.93 Million USD | -78.171% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -779.579% |
| Rezolute, Inc. | -68.45 Million USD | -303.243% |
| Clene Inc. | -49.5 Million USD | -457.644% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -1689.844% |
| BeyondSpring Inc. | -21.02 Million USD | -1212.927% |
| Synlogic, Inc. | -57.28 Million USD | -381.925% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -2219.603% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -2449.935% |
| Peak Bio, Inc. | -1259.26 USD | -21921981.222% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -638.75% |
| Krystal Biotech, Inc. | 10.93 Million USD | 2625.21% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -92.913% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | 15.087% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -5876.577% |
| MannKind Corporation | -11.93 Million USD | -2212.414% |
| Ikena Oncology, Inc. | -68.16 Million USD | -304.976% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -1213.614% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -197.048% |
| Gossamer Bio, Inc. | -179.81 Million USD | -53.521% |
| CohBar, Inc. | -11.96 Million USD | -2207.752% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -970.482% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -815.609% |
| Legend Biotech Corporation | -518.25 Million USD | 46.733% |
| Mural Oncology plc | -207.44 Million USD | -33.073% |
| Disc Medicine, Inc. | -76.42 Million USD | -261.193% |
| Champions Oncology, Inc. | -7.27 Million USD | -3694.063% |
| REGENXBIO Inc. | -263.49 Million USD | -4.767% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -2501.094% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -481.109% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -626.779% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -175.607% |
| Vaxart, Inc. | -82.46 Million USD | -234.755% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 82810.187% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -635.316% |
| Cellectis S.A. | -101.05 Million USD | -173.163% |
| Longeveron Inc. | -21.41 Million USD | -1189.198% |
| Repare Therapeutics Inc. | -93.79 Million USD | -194.315% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 48.495% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -287.888% |
| Revolution Medicines, Inc. | -436.36 Million USD | 36.738% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -4101.126% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -795.588% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -298.16% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -326.46% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -2713.74% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 107.627% |
| Denali Therapeutics Inc. | -145.22 Million USD | -90.09% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -229460.763% |
| Veru Inc. | -93.15 Million USD | -196.348% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -921.333% |
| Cingulate Inc. | -23.53 Million USD | -1072.962% |
| Passage Bio, Inc. | -102.06 Million USD | -170.479% |
| Context Therapeutics Inc. | -23.96 Million USD | -1051.951% |
| Exicure, Inc. | -16.91 Million USD | -1532.115% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -46.126% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -631.003% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -4142.235% |
| Nuvalent, Inc. | -126.21 Million USD | -118.712% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -2525.19% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -217.748% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -803.798% |
| OmniAb, Inc. | -50.61 Million USD | -445.36% |
| Anew Medical, Inc. | 1.34 Million USD | 20607.457% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -1620.511% |
| Lipocine Inc. | -16.35 Million USD | -1588.201% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -315.785% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -333.539% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -554.257% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -475.512% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -1292.043% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 49.019% |
| Ocugen, Inc. | -63.07 Million USD | -337.642% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -188.363% |
| Q32 Bio Inc. | -112.96 Million USD | -144.382% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -1505.724% |
| Alumis Inc. Common Stock | -154.99 Million USD | -78.109% |
| Equillium, Inc. | -13.33 Million USD | -1970.161% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -357.304% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -3355.955% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -1364.393% |
| Dominari Holdings Inc. | -22.88 Million USD | -1106.433% |
| Edesa Biotech, Inc. | -8.37 Million USD | -3196.421% |
| vTv Therapeutics Inc. | -20.25 Million USD | -1263.24% |
| Bio-Techne Corporation | 168.1 Million USD | 264.216% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | 21.595% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 314.241% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -126.587% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -627.631% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -145.074% |
| Nkarta, Inc. | -117.5 Million USD | -134.939% |
| BioCardia, Inc. | -11.57 Million USD | -2285.757% |
| Iterum Therapeutics plc | -38.37 Million USD | -619.439% |